<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00578474</url>
  </required_header>
  <id_info>
    <org_study_id>C-05-35</org_study_id>
    <nct_id>NCT00578474</nct_id>
  </id_info>
  <brief_title>A Phase III Study of an Otic Formulation in Acute Otitis Media With Tympanostomy Tubes</brief_title>
  <official_title>Safety and Efficacy of a Topical Otic Formulation in the Treatment of Acute Otitis Media With Otorrhea Through Tympanostomy Tubes (AOMT)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Alcon Research</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Alcon Research</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine if an otic formulation is safe and effective in
      treating middle ear infections in patients with ear tubes.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>December 2005</start_date>
  <completion_date type="Actual">August 2008</completion_date>
  <primary_completion_date type="Actual">August 2008</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Clinical cure rate at the test of cure visit as determined by the investigator</measure>
    <time_frame>From baseline</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time to cessation of otorrhea</measure>
    <time_frame>From baseline</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Microbiological outcome</measure>
    <time_frame>From baseline</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Treatment failures</measure>
    <time_frame>From baseline</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">911</enrollment>
  <condition>Acute Otitis Media</condition>
  <arm_group>
    <arm_group_label>Moxidex</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Moxidex otic solution</description>
  </arm_group>
  <arm_group>
    <arm_group_label>FLOXIN</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Ofloxacin otic solution</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Moxidex otic solution</intervention_name>
    <description>4 drops into the infected ear(s) twice daily (morning and evening) for 7 days</description>
    <arm_group_label>Moxidex</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ofloxacin otic solution</intervention_name>
    <description>5 drops into the infected ear(s) twice daily (morning and evening) for 10 days</description>
    <arm_group_label>FLOXIN</arm_group_label>
    <other_name>FLOXIN</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Tympanostomy tubes</intervention_name>
    <description>Tubes surgically inserted through the ear drum for the treatment of recurrent otitis media in children</description>
    <arm_group_label>Moxidex</arm_group_label>
    <arm_group_label>FLOXIN</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  6 months to 12 years old

          -  Ear tubes in one or both ears

          -  Ear drainage visible by the parent / guardian

          -  Ear drainage less than 21 days

          -  Ear tube may not be silver oxide, silver salt, t-type tube or long-shafted tube

          -  Patient may not have non-tube otorrhea

          -  Patient may not have had otic surgery other than tube placement in the last year

          -  Patient may not be a menarchal female

          -  Diabetic patients are not eligible

          -  Patient may not have any disease or condition that would negatively affect the conduct
             of the study

          -  Patient may not require any other systemic antimicrobial therapy during the study

          -  Patient must meet certain medication washouts to be eligible

          -  Analgesic use (other than acetaminophen) is not allowed

          -  Patient may not be pre-disposed to neurosensory hearing loss

          -  Other protocol-defined inclusion criteria may apply

        Exclusion Criteria:

          -  Age related

          -  Other protocol-defined exclusion criteria may apply
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Months</minimum_age>
    <maximum_age>12 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Contact Alcon Call Center</last_name>
    <role>Study Director</role>
    <affiliation>1-888-451-3937</affiliation>
  </overall_official>
  <removed_countries>
    <country>United States</country>
  </removed_countries>
  <verification_date>November 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 19, 2007</study_first_submitted>
  <study_first_submitted_qc>December 20, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 21, 2007</study_first_posted>
  <disposition_first_submitted>November 28, 2012</disposition_first_submitted>
  <disposition_first_submitted_qc>November 28, 2012</disposition_first_submitted_qc>
  <disposition_first_posted type="Estimate">November 30, 2012</disposition_first_posted>
  <last_update_submitted>November 29, 2012</last_update_submitted>
  <last_update_submitted_qc>November 29, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 3, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Acute otitis media</keyword>
  <keyword>Tympanostomy tubes</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Otitis</mesh_term>
    <mesh_term>Otitis Media</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pharmaceutical Solutions</mesh_term>
    <mesh_term>Ofloxacin</mesh_term>
    <mesh_term>Levofloxacin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted, but a results disposition has been submitted           -->
</clinical_study>

